Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Georgia on +44 1494 818 012 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Georgia Barnes
Recruitment Consultant
+44 1494 818 012

Zenopa keeps things professionally simple. Form the commitment to work with and help you to gain a position through to working for them as a contractor.
Angela, 2012

Novo Nordisk to open children's diabetes clinic in Bangladesh

21 March 2012 00:00 in Pharmaceutical Company Product News

Novo Nordisk has announced the launch of a new clinic for children affected by type 1 diabetes in the impoverished nation of Bangladesh.

The clinic will be the largest of its kind in the country and will be incorporated as part of the facilities at Bangladesh Institute for Research in Diabetes, Endocrinology and Metabolism Hospital.

It will include four clinical rooms for testing and treatment, with around 1,500 children to be enrolled, while a conference hall will also be provided for professional training and educational sessions for families about disease management.

This comes as part of the company's Changing Diabetes in Children scheme, which aims to create a treatment infrastructure for young diabetes sufferers in nine developing nations.

Jesper Hoiland, senior vice-president of Novo Nordisk's international operations, said: "Bangladesh is an incredibly important country for us to learn how to work through partnerships to ease the lives of the millions of patients here."

This comes after the company established a new centre for type 1 diabetes research in Seattle earlier this year.ADNFCR-8000103-ID-801322674-ADNFCR

Other news stories from 21/03/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd